These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 18758051)

  • 1. Endogenous modulators for drug dependence.
    Yamada K
    Biol Pharm Bull; 2008 Sep; 31(9):1635-8. PubMed ID: 18758051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-addictive and anti-addictive factors for drug dependence.
    Yamada K
    Nagoya J Med Sci; 2008 Aug; 70(3-4):67-72. PubMed ID: 18954024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dynamics and functional analysis of cytokines/proteinases with drug dependence].
    Yamada K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Nov; 28(5-6):195-201. PubMed ID: 19108506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro- and anti-addictive neurotrophic factors and cytokines in psychostimulant addiction: mini review.
    Yamada K; Nabeshima T
    Ann N Y Acad Sci; 2004 Oct; 1025():198-204. PubMed ID: 15542718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genes and molecules that can potentiate or attenuate psychostimulant dependence: relevance of data from animal models to human addiction.
    Niwa M; Yan Y; Nabeshima T
    Ann N Y Acad Sci; 2008 Oct; 1141():76-95. PubMed ID: 18991952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of BDNF and GDNF in drug reward and relapse: a review.
    Ghitza UE; Zhai H; Wu P; Airavaara M; Shaham Y; Lu L
    Neurosci Biobehav Rev; 2010 Nov; 35(2):157-71. PubMed ID: 19914287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of glial cell line-derived neurotrophic factor, tumor necrosis factor-alpha, and an inducer of these factors in drug dependence.
    Niwa M; Nitta A; Yamada K; Nabeshima T
    J Pharmacol Sci; 2007 Jun; 104(2):116-21. PubMed ID: 17538232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pro- and anti-addictive factors related to drug addiction].
    Yamada K; Nagai T; Nakajima A; Nabeshima T
    Nihon Yakurigaku Zasshi; 2005 Jul; 126(1):49-53. PubMed ID: 16141618
    [No Abstract]   [Full Text] [Related]  

  • 9. [Regulation by tissue plasminogen activator of rewarding effects of drugs of abuse].
    Nagai T; Takuma K; Nabeshima T; Yamada K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Feb; 28(1):1-6. PubMed ID: 18411702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neurobiological basis of drug addiction].
    Fernández-Espejo E
    Rev Neurol; 2002 Apr 1-15; 34(7):659-64. PubMed ID: 12080517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug addiction. Part II. Neurobiology of addiction.
    Vetulani J
    Pol J Pharmacol; 2001; 53(4):303-17. PubMed ID: 11990077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tissue plasminogen activator/plasmin system may act through cleavage of pro-BDNF to increase risk of substance abuse.
    Hsu CD; Tsai SJ
    CNS Spectr; 2010 Jun; 15(6):350. PubMed ID: 20629271
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of Dopamine Signaling in Drug Addiction.
    Chen W; Nong Z; Li Y; Huang J; Chen C; Huang L
    Curr Top Med Chem; 2017; 17(21):2440-2455. PubMed ID: 28474551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug addiction as a physical disease: the role of physical dependence and other chronic drug-induced neurophysiological changes in compulsive drug self-administration.
    Lyvers M
    Exp Clin Psychopharmacol; 1998 Feb; 6(1):107-25. PubMed ID: 9526151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update of neurotrophic factors in neurobiology of addiction and future directions.
    Koskela M; Bäck S; Võikar V; Richie CT; Domanskyi A; Harvey BK; Airavaara M
    Neurobiol Dis; 2017 Jan; 97(Pt B):189-200. PubMed ID: 27189755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inducer for glial cell line-derived neurotrophic factor and tumor necrosis factor-alpha protects against methamphetamine-induced rewarding effects and sensitization.
    Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Shen L; Noda Y; Furukawa S; Nabeshima T
    Biol Psychiatry; 2007 Apr; 61(7):890-901. PubMed ID: 17046726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of tissue plasminogen activator in the rewarding effect of nicotine].
    Nagai T; Yamada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):151-7. PubMed ID: 18646640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction.
    Koob GF
    Psychopharmacology (Berl); 2017 May; 234(9-10):1315-1332. PubMed ID: 28050629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors.
    Weiss F; Ciccocioppo R; Parsons LH; Katner S; Liu X; Zorrilla EP; Valdez GR; Ben-Shahar O; Angeletti S; Richter RR
    Ann N Y Acad Sci; 2001 Jun; 937():1-26. PubMed ID: 11458532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurobiology of addiction. Toward the development of new therapies.
    Koob GF
    Ann N Y Acad Sci; 2000; 909():170-85. PubMed ID: 10911930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.